Inhibrx Biosciences, Inc. INBX

99.61 (0.79) (0.79%) as of 25 Sep
Market cap
$1.5B
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Cash and Short Term Investments
133.34 161.66 124.22 153.09

+8 more quarters

Receivables
0.13 0.19 0.18 0.84
Total current assets
142.21 171.34 132.83 161.42
Property, Plant, Equpment (Net)
2.69 3.20 3.73 4.31
Long-term assets (Other)
4.77 4.38 4.38 5.74
Total non-current assets
12.01 12.63 13.65 16.05
Total Assets
154.22 183.97 146.48 177.47
Accounts Payable
9.80 8.76 5.94 6.77
Accrued Expenses
15.77 15.34 25.53 26.96
Total current liabilities
28.06 26.51 33.80 35.98
Long Term Debt (Total)
176.29 174.99 100.56 99.92
Total non-current liabilities
179.14 178.49 104.69 104.66
Total liabilities
207.20 205.00 138.49 140.64
Additional Paid In Capital
263.30 258.59 254.18 250.18
Common Stock (Net)
0.00 0.00 0.00 0.00
Retained Earnings
(316.28) (279.63) (246.19) (213.35)
Common Equity (Total)
(52.98) (21.03) 7.99 36.83
Shareholders Equity (Total)
(52.98) (21.03) 7.99 36.83
Shareholders Equity and Liabilities (Total)
154.22 183.97 146.48 177.47
Shares (Common)
14.71 14.61 14.58 14.50
Shareholders Equity (Tangible)
(52.98) (21.03) 7.99 36.83
Net Debt
42.94 13.34 (23.66) (53.17)
Total Debt
176.29 174.99 100.56 99.92

Fold the line items

In millions of $ except per-share values · columns are period end dates